Eli Lilly shares could remain under the microscope on Wednesday after falling sharply Tuesday as the pharmaceutical giant lowered its 2024 full-year forecast. Monitor these key price levels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback